Anthony Sinskey
Founder chez YIELD10 BIOSCIENCE, INC.
Fortune : 24 424 $ au 31/03/2024
Profil
Anthony J.
Sinskey is the founder of Yield10 Bioscience, Inc. (founded in 1992) and Tepha, Inc. (founded in 1998).
He is currently a Director at Akeso Biomedical, Inc., SweeGen, Inc., ABEC, Inc., and the MIT Center for Biomedical Innovation.
He is also a Professor at the Massachusetts Institute of Technology since 1968.
In the past, he served as an Independent Director at Merrimack Pharmaceuticals, Inc. (founded in 1993) from 2011 to 2015.
He was also a Director at Apex Bioventures Acquisition Corp.
from 2006 to 2009 and an Advisor at Kodiak Ventures Management Company Inc. He holds a doctorate degree from the Massachusetts Institute of Technology (conferred in 1966) and an undergraduate degree from the University of Illinois.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
YIELD10 BIOSCIENCE, INC.
0,54% | 28/03/2024 | 64 274 ( 0,54% ) | 24 424 $ | 31/03/2024 |
Postes actifs de Anthony Sinskey
| Sociétés | Poste | Début |
|---|---|---|
| YIELD10 BIOSCIENCE, INC. | Founder | 01/06/1992 |
| SWEEGEN, INC. | Director/Board Member | - |
Tepha, Inc.
 Tepha, Inc. Medical SpecialtiesHealth Technology Tepha, Inc. develops and commercializes medical devices and biomaterial technology. The firm’s products include monofilament suture, monofilament mesh, surgical film and composite mesh. The company was founded by Anthony J. Sinskey and Simon Williams in 1998 and is headquartered in Lexington, MA. | Founder | 01/01/1998 |
| Massachusetts Institute of Technology | Corporate Officer/Principal | 01/01/1968 |
ABEC, Inc.
 ABEC, Inc. Engineering & ConstructionIndustrial Services ABEC, Inc. is a private company that provides engineered process solutions and services for manufacturing in the biotech industry. ABEC is based in Bethlehem, PA and has subsidiaries in Ireland. The majority of the world's pharmaceutical and biotech companies are ABEC customers, with many of today's leading therapies manufactured by processes and equipment engineered, manufactured, installed, and serviced by ABEC. ABEC's unique value is based on long experience, complete in-house capabilities, a custom, flexible approach, and long-term credibility. Whether adding capacity or improving existing facilities, ABEC's turn-key solutions and support services reduce overall cost and time to market while delivering maximum productivity. The company was founded in 1974 by Jack Wilson, and the CEO is Scott Pickering. | Director/Board Member | - |
MIT Center for Biomedical Innovation
 MIT Center for Biomedical Innovation Miscellaneous Commercial ServicesCommercial Services MIT Center for Biomedical Innovation improves global health by overcoming obstacles to the development and implementation of biomedical innovation. Its programs include Biomanufacturing Program, Consortium on Adventitious Agent Contamination in Biomanufacturing and New Drug Development Paradigms program. The company was founded by Frank Lennox Douglas in 2005 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Akeso Biomedical, Inc.
 Akeso Biomedical, Inc. Financial ConglomeratesFinance Akeso Biomedical, Inc. develops solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds using a broad-spectrum iron complex chemistry. Its product includes Fe3C compounds for the prevention of foodborne illnesses, and the treatment of bacterial infections, including chronic wounds and medical devices. The company was founded in 2014 and is headquartered in Burlington, MA. | Director/Board Member | - |
Anciens postes connus de Anthony Sinskey
| Sociétés | Poste | Fin |
|---|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Founder | 30/01/2015 |
Apex Bioventures Acquisition Corp.
 Apex Bioventures Acquisition Corp. Financial ConglomeratesFinance The Company is a blank check company. It is formed to acquire one or more domestic or foreign operating business in the healthcare industry through merger, capital stock exchange, asset acquisition or other similar business combination. The Company is in the development stage. On February 5, 2008, the Company entered into an Agreement and Plan of Merger with Dynogen Pharmaceuticals, Inc and its acting representatives. | Director/Board Member | 04/06/2009 |
| ░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
Formation de Anthony Sinskey
| Massachusetts Institute of Technology | Doctorate Degree |
| University of Illinois | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| YIELD10 BIOSCIENCE, INC. | Process Industries |
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| SWEEGEN, INC. | Consumer Non-Durables |
| Entreprise privées | 6 |
|---|---|
Tepha, Inc.
Tepha, Inc. Medical SpecialtiesHealth Technology Tepha, Inc. develops and commercializes medical devices and biomaterial technology. The firm’s products include monofilament suture, monofilament mesh, surgical film and composite mesh. The company was founded by Anthony J. Sinskey and Simon Williams in 1998 and is headquartered in Lexington, MA. | Health Technology |
Apex Bioventures Acquisition Corp.
Apex Bioventures Acquisition Corp. Financial ConglomeratesFinance The Company is a blank check company. It is formed to acquire one or more domestic or foreign operating business in the healthcare industry through merger, capital stock exchange, asset acquisition or other similar business combination. The Company is in the development stage. On February 5, 2008, the Company entered into an Agreement and Plan of Merger with Dynogen Pharmaceuticals, Inc and its acting representatives. | Finance |
Akeso Biomedical, Inc.
Akeso Biomedical, Inc. Financial ConglomeratesFinance Akeso Biomedical, Inc. develops solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds using a broad-spectrum iron complex chemistry. Its product includes Fe3C compounds for the prevention of foodborne illnesses, and the treatment of bacterial infections, including chronic wounds and medical devices. The company was founded in 2014 and is headquartered in Burlington, MA. | Finance |
Kodiak Ventures Management Company Inc
 Kodiak Ventures Management Company Inc Investment ManagersFinance Kodiak Ventures Management Company Inc (Kodiak Venture Partners) is a venture capital firm founded in 1999 by Jim H. Furneaux and David Furneaux. The firm is headquartered in Wellesley, Massachusetts. | Finance |
ABEC, Inc.
ABEC, Inc. Engineering & ConstructionIndustrial Services ABEC, Inc. is a private company that provides engineered process solutions and services for manufacturing in the biotech industry. ABEC is based in Bethlehem, PA and has subsidiaries in Ireland. The majority of the world's pharmaceutical and biotech companies are ABEC customers, with many of today's leading therapies manufactured by processes and equipment engineered, manufactured, installed, and serviced by ABEC. ABEC's unique value is based on long experience, complete in-house capabilities, a custom, flexible approach, and long-term credibility. Whether adding capacity or improving existing facilities, ABEC's turn-key solutions and support services reduce overall cost and time to market while delivering maximum productivity. The company was founded in 1974 by Jack Wilson, and the CEO is Scott Pickering. | Industrial Services |
MIT Center for Biomedical Innovation
MIT Center for Biomedical Innovation Miscellaneous Commercial ServicesCommercial Services MIT Center for Biomedical Innovation improves global health by overcoming obstacles to the development and implementation of biomedical innovation. Its programs include Biomanufacturing Program, Consortium on Adventitious Agent Contamination in Biomanufacturing and New Drug Development Paradigms program. The company was founded by Frank Lennox Douglas in 2005 and is headquartered in Cambridge, MA. | Commercial Services |
